There exists a weak negative correlation between serum nesfatin-1 level and BMI, LDL cholesterol, and postprandial plasma glucose in patients with T2DM associated with microvascular complications (Table 3). This evidence concerns the gene NUCB2 and type 2 diabetes mellitus.